Literature DB >> 8111788

Nitric oxide biology: implications for cardiovascular therapeutics.

J B Warren1, F Pons, A J Brady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8111788     DOI： 10.1093/cvr/28.1.25

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  8 in total

Review 1.  Nitric oxide: an emerging role in cardioprotection?

Authors:  R D Rakhit; M S Marber
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.

Authors:  S Lal; N Sutiman; L L Ooi; Z W Wong; N S Wong; P C S Ang; B Chowbay
Journal:  Pharmacogenomics J       Date:  2016-03-15       Impact factor: 3.550

Review 3.  New approaches to the prevention of atherosclerosis.

Authors:  M Naito; T Hayashi; A Iguchi
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

4.  Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia.

Authors:  T Klotz; M J Mathers; W Bloch; W Nayal; U Engelmann
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

5.  Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.

Authors:  Y-J Yang; J-L Zhao; S-J You; Y-J Wu; Z-C Jing; W-X Yang; L Meng; Y-W Wang; R-L Gao
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

6.  Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart.

Authors:  Peter Dazert; Konrad Meissner; Silke Vogelgesang; Björn Heydrich; Lothar Eckel; Michael Böhm; Rolf Warzok; Reinhold Kerb; Ulrich Brinkmann; Elke Schaeffeler; Matthias Schwab; Ingolf Cascorbi; Gabriele Jedlitschky; Heyo K Kroemer
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 7.  Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.

Authors:  Jeff S Isenberg; William A Frazier; Murali C Krishna; David A Wink; David D Roberts
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

Review 8.  Thrombospondin-1: a physiological regulator of nitric oxide signaling.

Authors:  J S Isenberg; W A Frazier; D D Roberts
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.